Serum Life Science Europe

Executive Summary

Serum Life Science Europe GmbH (SLS Europe) is a German biopharmaceutical consultancy and service provider founded in 2002, based in Marburg. The company offers expert operational, scientific, and regulatory support for product development, including regulatory submissions, translational project management, and clinical trial sponsorship. In parallel, SLS Europe manages its own proprietary pipeline of vaccine and immunotherapy candidates, currently at the preclinical stage. With over two decades of experience, the firm combines deep regulatory expertise with a growing internal R&D focus, positioning itself as a hybrid player in the European biotech landscape. Its service business provides a stable revenue base while the pipeline offers upside potential, albeit with typical early-stage risk.

Upcoming Catalysts (preview)

• Q4 2026Regulatory submission for lead vaccine candidate35% success
• Q2 2027Initiation of GLP toxicology studies for immunotherapy program40% success
• Q1 2027Strategic partnership or licensing deal with larger pharma30% success